Patents by Inventor Kin T. Yu

Kin T. Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KINASE INHIBITOR
    Publication number: 20140142110
    Abstract: The invention is directed to a compound of formula (I): and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
    Type: Application
    Filed: January 28, 2014
    Publication date: May 22, 2014
    Applicant: SANOFI
    Inventors: Timothy A. GILLESPY, Elizabeth M. ALLEN, Kin T. YU, Asher ZILBERSTEIN
  • Kinase inhibitor
    Patent number: 8658649
    Abstract: The invention is directed to a compound of formula (I): and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: February 25, 2014
    Assignee: Sanofi
    Inventors: Timothy A. Gillespy, Paul Eynott, Elizabeth M. Allen, Kin T. Yu, Asher Zilberstein
  • KINASE INHIBITOR
    Publication number: 20100035884
    Abstract: The invention is directed to a compound of formula (I): and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
    Type: Application
    Filed: March 10, 2009
    Publication date: February 11, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Timothy A. GILLESPY, Paul EYNOTT, Elizabeth M. ALLEN, Kin T. YU, Asher ZILBERSTEIN
  • Luciferase reporter bioassay of parathyroid hormone compounds
    Patent number: 6720153
    Abstract: This invention is directed to a bioassay for determining the functionality of parathyroid hormone compounds. More particularly, this invention is directed to a bioassay wherein the compound to be tested is added to a culture of parathyroid hormone receptor expressing cells bearing a reporter gene under the transcriptional control of multiple c-AMP responsive elements.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: April 13, 2004
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Richard F. Labaudiniere, Kin T. Yu, Gregg R. Crumley, Clarence C. Morse
  • Treatment of conditions requiring enhanced oxygen availability of mammalian tissues
    Patent number: 5015663
    Abstract: Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
    Type: Grant
    Filed: March 5, 1990
    Date of Patent: May 14, 1991
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: John T. Suh, Robert G. Pendleton, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber
  • Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
    Patent number: 4948582
    Abstract: Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
    Type: Grant
    Filed: May 11, 1989
    Date of Patent: August 14, 1990
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: John T. Suh, Robert G. Pendleton, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber
  • Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
    Patent number: 4861795
    Abstract: Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
    Type: Grant
    Filed: June 23, 1988
    Date of Patent: August 29, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: John T. Suh, Robert G. Pendelton, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber
  • Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
    Patent number: 4849416
    Abstract: Disclosed are pharmaceutical compositions containing certain heterocylcic sulphonamido azo compounds for enhancing oxygen availability to mammalian tissue.
    Type: Grant
    Filed: July 25, 1988
    Date of Patent: July 18, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Robert G. Pendleton, Charles E. Pendley, II, John T. Suh, Kin T. Yu, Paul R. Menard, Tihamer Herczeg